Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor The study by Dr Xing and colleagues1 explored the association between the BRAF V600E mutation and mortality in patients with papillary thyroid cancer (PTC) in a large retrospective cohort of 1849 patients from 13 centers worldwide. The authors concluded that the BRAF mutation was significantly associated with cancer-related mortality.
Ciarrocchi A, Cavuto S, Piana S. BRAF V600E Mutation and Papillary Thyroid Cancer. JAMA. 2013;310(5):534. doi:10.1001/jama.2013.8589